JP2023505227A5 - - Google Patents

Info

Publication number
JP2023505227A5
JP2023505227A5 JP2022533459A JP2022533459A JP2023505227A5 JP 2023505227 A5 JP2023505227 A5 JP 2023505227A5 JP 2022533459 A JP2022533459 A JP 2022533459A JP 2022533459 A JP2022533459 A JP 2022533459A JP 2023505227 A5 JP2023505227 A5 JP 2023505227A5
Authority
JP
Japan
Prior art keywords
compound
pharmaceutical composition
composition according
crystalline form
species
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022533459A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023505227A (ja
Filing date
Publication date
Priority claimed from GBGB1917867.2A external-priority patent/GB201917867D0/en
Application filed filed Critical
Publication of JP2023505227A publication Critical patent/JP2023505227A/ja
Publication of JP2023505227A5 publication Critical patent/JP2023505227A5/ja
Pending legal-status Critical Current

Links

JP2022533459A 2019-12-06 2020-12-04 トリアゾール抗真菌化合物pc945の多形 Pending JP2023505227A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1917867.2 2019-12-06
GBGB1917867.2A GB201917867D0 (en) 2019-12-06 2019-12-06 Polymorphs
PCT/GB2020/053107 WO2021111142A1 (en) 2019-12-06 2020-12-04 Polymorphs of triazole antifungal compound pc945

Publications (2)

Publication Number Publication Date
JP2023505227A JP2023505227A (ja) 2023-02-08
JP2023505227A5 true JP2023505227A5 (cg-RX-API-DMAC7.html) 2023-12-13

Family

ID=69171938

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022533459A Pending JP2023505227A (ja) 2019-12-06 2020-12-04 トリアゾール抗真菌化合物pc945の多形

Country Status (26)

Country Link
US (2) US12491182B2 (cg-RX-API-DMAC7.html)
EP (2) EP4069690B1 (cg-RX-API-DMAC7.html)
JP (1) JP2023505227A (cg-RX-API-DMAC7.html)
KR (1) KR20220110726A (cg-RX-API-DMAC7.html)
CN (1) CN114746415B (cg-RX-API-DMAC7.html)
AU (1) AU2020397613A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022006259A2 (cg-RX-API-DMAC7.html)
CA (1) CA3155829A1 (cg-RX-API-DMAC7.html)
CL (1) CL2022001464A1 (cg-RX-API-DMAC7.html)
CO (1) CO2022007808A2 (cg-RX-API-DMAC7.html)
DK (1) DK4069690T3 (cg-RX-API-DMAC7.html)
ES (1) ES3000984T3 (cg-RX-API-DMAC7.html)
FI (1) FI4069690T3 (cg-RX-API-DMAC7.html)
GB (1) GB201917867D0 (cg-RX-API-DMAC7.html)
HR (1) HRP20250042T1 (cg-RX-API-DMAC7.html)
HU (1) HUE069799T2 (cg-RX-API-DMAC7.html)
IL (1) IL293401B1 (cg-RX-API-DMAC7.html)
LT (1) LT4069690T (cg-RX-API-DMAC7.html)
MX (1) MX2022006654A (cg-RX-API-DMAC7.html)
PL (1) PL4069690T3 (cg-RX-API-DMAC7.html)
PT (1) PT4069690T (cg-RX-API-DMAC7.html)
RS (1) RS66401B1 (cg-RX-API-DMAC7.html)
SA (1) SA522432879B1 (cg-RX-API-DMAC7.html)
SI (1) SI4069690T1 (cg-RX-API-DMAC7.html)
SM (1) SMT202400514T1 (cg-RX-API-DMAC7.html)
WO (1) WO2021111142A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016087880A1 (en) 2014-12-05 2016-06-09 Pulmocide Limited Antimycotic compound
CN117510488B (zh) * 2022-07-28 2025-12-05 博瑞制药(苏州)有限公司 一种硫酸艾沙康唑的制备方法
CN117330660A (zh) * 2023-09-14 2024-01-02 广州医科大学附属第一医院(广州呼吸中心) Uplc-ms/ms联用检测艾沙康唑的方法及应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1292472C (en) 1985-12-03 1991-11-26 Alfonsus Guilielmus Knaeps Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles
AU2811689A (en) 1987-11-20 1989-06-14 Schering Corporation Tri-and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof
US5039676A (en) 1990-05-11 1991-08-13 Schering Corporation Tri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereof
DK0736030T3 (da) 1993-12-21 2001-10-29 Schering Corp Fungicide tetrahydrofuraner
US5714490A (en) 1993-12-21 1998-02-03 Schering Corporation Tetrahydrofuran antifungals
US5486625A (en) 1994-07-08 1996-01-23 Schering Corporation Process for the preparation of chiral intermediates useful for the synthesis of antifungal agents
ES2199291T3 (es) 1995-06-02 2004-02-16 Schering Corporation Antifungicos de tetrahidrofurano.
EP0957101A1 (en) 1998-05-14 1999-11-17 Janssen Pharmaceutica N.V. Water soluble azoles as broad-spectrum antifungals
PL212985B1 (pl) 2001-04-03 2012-12-31 Schering Corp Ciekla zawiesina zawierajaca przeciwgrzybiczo skuteczna ilosc posakonazolu oraz zastosowanie zmikronizowanych czastek posakonazolu
EP2141159A1 (en) * 2008-07-03 2010-01-06 Sandoz AG A Crystalline form of posaconazole
WO2013036866A1 (en) 2011-09-07 2013-03-14 The Johns Hopkins University Itraconazole analogs and use thereof
WO2016087880A1 (en) * 2014-12-05 2016-06-09 Pulmocide Limited Antimycotic compound

Similar Documents

Publication Publication Date Title
JP2017536382A5 (cg-RX-API-DMAC7.html)
US6407129B1 (en) Azole compounds, their production and their use
JP2011500779A5 (cg-RX-API-DMAC7.html)
FI4069690T3 (fi) Triatsolisienilääkeyhdiste pc945:n polymorfeja
JP2017536385A5 (cg-RX-API-DMAC7.html)
KR101639456B1 (ko) 포사코나졸의 결정질 형태
CN107001343B (zh) 抗真菌的化合物
EP1511490A2 (en) Novel conazole crystalline forms and related processes, pharmaceutical compositions and methods
JP5635075B2 (ja) 抗真菌医薬組成物
JP2017536371A5 (cg-RX-API-DMAC7.html)
US20050070551A1 (en) Novel crystalline forms of conazoles and methods of making and using the same
US4782059A (en) Method of controlling mycotic infections and compositions therefor
WO2018073839A1 (en) Amorphous osimertinib mesylate, processes for its preparation and solid amorphous dispersions thereof
JPH11504931A (ja) 抗真菌組成物
US20090088443A1 (en) Novel crystalline forms of conazoles and methods of making and using the same
EP2255785A2 (en) Stable emulsion composition
US20080032994A1 (en) Modified azole compounds as antifungal and antibacterial agents
US20070293674A1 (en) Novel Saperconazole Crystalline Forms and Related Processes, Pharmaceutical Compositions and Methods
EP2027850A1 (en) Pharmaceutical compositions containing voriconazole
EP1120116A1 (en) Antimycotic drug composition
BRPI9811679B1 (pt) antifúngicos de 1-{4-[4-(4-{[4-fenil-4-(1 h-1,2,4-triazol-1-ilmetil)-1,3-dioxolan-2-il]metóxi}fenil)piperazin-1-il]fenil}imidazolidin-2-onas substituídas
HUP0200872A2 (hu) Antifungális hatású éterek, eljárás az előállításukra, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
EA048470B1 (ru) Полиморфы триазольного противогрибкового соединения pc945
WO2019106571A1 (en) Dosing regimens for the treatment of fungal infections
EP1718640A1 (en) Novel crystalline forms of conazoles and methods of making and using the same